Results 141 to 150 of about 868 (155)

Treatment of unresectable hepatocellular carcinoma using intra-arterial yttrium-90 (TheraSphere): Report of a pilot trial

Gastroenterology, 2003
Veslav Stecevic, Riad Salem, Stuart C. Gordon   +2 more
openaire   +1 more source

Baseline Albumin/Bilirubin Ratio (ABR) as a Predictor of Yttrium-90 Microsphere (TheraSphere) Treatment Outcome

International Journal of Radiation Oncology*Biology*Physics, 2008
D.A. Kelly, F. Brunk, A. Sen, J.P. Flynn, M. West, A. Movahed, F. Pascual   +6 more
openaire   +1 more source

TheraSphere & Treatment of Unresectable Primary or Unresectable Secondary Liver Cancer

Case Medical Research, 2019
openaire   +1 more source

Abstract No. 167: The use of therasphere in metastatic liver tumors: risk factors associated with poor prognosis

Journal of Vascular and Interventional Radiology, 2012
D. Conners, J.J. Zechlinski, W.S. Rilling   +2 more
openaire   +1 more source

90Y Microsphere (TheraSphere) Treatment for Unresectable Colorectal Cancer Metastases of the Liver: Response to Treatment at Targeted Doses of 135–150 Gy as Measured by [18F]Fluorodeoxyglucose Positron Emission Tomography and Computed Tomographic Imaging

Journal of Vascular and Interventional Radiology, 2005
Riad Salem, Robert J Lewandowski, Vanessa L. Gates   +2 more
exaly  

Quality of life in patients diagnosed with primary hepatocellular carcinoma: Hepatic arterial infusion of Cisplatin versus 90-Yttrium microspheres (Therasphere®)

Psycho-Oncology, 2004
Jennifer L Steel, Brian I. Carr, Andrew Baum   +2 more
exaly  

90yttrium-labeled glass microspheres (therasphere) given to the hepatic artery for treatment of unresectable HCC: initial clinical experience

European Journal of Cancer, 2001
B. Carr, M. Sheetz, M. Brown, F. Torok, B. McCook, A. Zajko, L. Collins, M. France   +7 more
openaire   +1 more source

Selektive interne Radiotherapie mit Yttrium-90 Glasmikrosphären (TheraSphere) bei intrahepatisch fortgeschrittenem hepatozellulärem Karzinom

Zeitschrift für Gastroenterologie, 2009
A El Fouly, M Hamami, JM Ertle, G Antoch, A Scherag, A Bockisch, G Gerken, P Hilgard   +7 more
openaire   +1 more source

Non-Interventional Registry Study to Evaluate the Effectiveness of TheraSphere® in the Treatment of Hepatocellular Carcinoma (HCC)

Case Medical Research, 2019
openaire   +1 more source

Abstract No. 32: Hepatic Vein Tumor Thrombus as a Risk Factor for Pulmonary Deposition of Microspheres during TheraSphere Therapy

Journal of Vascular and Interventional Radiology, 2008
C.J. Fleming, J.C. Andrews, G.A. Wiseman, D.N. Gansen, L.R. Roberts   +4 more
openaire   +1 more source